• Breaking News

    CNIC researchers identify a very early marker of cardiac damage triggered by cancer treatment

    Researchers at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have identified a very early marker of cardiac damage in patients undergoing therapy with anthracyclines, a family of drugs commonly used to treat cancer. This finding will enable the early diagnosis of the cardiotoxicity associated with this group of widely used chemotherapy drugs.

    from EurekAlert! - Breaking News http://bit.ly/2BHa0bc

    No comments

    Post Top Ad


    Post Bottom Ad